XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Securities (Narrative) (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
security
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
security
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Marketable Securities [Line Items]          
Number of securities past due or on nonaccrual     0    
Securities evaluated for other than temporary impairment 121   121    
Available-for-sale Securities Pledged as Collateral | $ $ 46,865,000   $ 46,865,000    
Net gain from sale of available-for-sale securities | $ 42,000   82,000    
Available for sale securities in an unrealized loss position for credit related impairment | $     0    
Debt securities, available-for-sale, allowance for credit Loss | $ 0   0    
Allowance for credit losses on held-to-maturity securities | $ 0   0   $ 0
Proceeds from sale of securities available-for-sale | $ $ 8,754,000 $ 0 $ 30,298,000 $ 0  
Publicly Traded Domestic Corporations [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 13   13    
U.S. Agency Obligations [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 55   55    
Municipals [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 53   53    
Non-rated [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 6   6    
S&P Rated AAA [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 28   28    
S&P Rated AA [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 81   81    
S&P Rated A [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 3   3    
S&P Rated BBB [Member]          
Marketable Securities [Line Items]          
Securities evaluated for other than temporary impairment 3   3